. Author manuscript; available in PMC: 2014 Apr 9.

Published in final edited form as: Int J Tuberc Lung Dis. 2012 Jul 12;16(9):1162–1167. doi: 10.5588/ijtld.12.0046

Table 1.

Demographic, clinical and drug resistance characteristics

Characteristic	Any FQ exposure (n = 214) n (%)	No FQ exposure (n = 395) n (%)	P value
Age, years, median [IQR]	53 [40–73]	43 [29–59]	<0.001
Male	134 (63)	256 (65)	0.60
Black race	79 (37)	159 (40)	0.42
Hispanic ethnicity	24 (11)	69 (18)	0.04
US-born	173 (81)	261 (66)	<0.001
HIV-positive	25/201 (12)	34/385 (9)	0.17
Drug resistance
FQs	8/176 (5)	1/265 (0)	0.002
Isoniazid	7/183 (4)	6/271 (2)	0.31
Rifampin	3/184 (2)	0/271 (0)	0.04
Pyrazinamide	4/180 (2)	11/268 (4)	0.28
Ethambutol	2/184 (1)	0/271 (0)	0.09

FQ = fluoroquinolone; IQR = interquartile range; HIV = human immunodeficiency virus.